Abstract
Mycobacterium tuberculosis presents unique challenges in the peritransplant period. Here, we describe a case of disseminated tuberculosis following renal transplantation with alemtuzumab induction immunosuppression in a patient with remotely treated pulmonary tuberculosis and ongoing risk factors for re-infection. We also review the available literature regarding the prevalence of tuberculosis infection following solid organ transplant and management of high-risk patients, including the role for isoniazid preventative therapy.
Original language | English (US) |
---|---|
Article number | bcr-2016-217998 |
Journal | BMJ case reports |
Volume | 2016 |
DOIs | |
State | Published - 2016 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)